Melinta Expands Portfolio, TMC Narrows Focus To LDL Reduction With Anti-Infective Deal

 
• By Joseph Haas

A transaction bringing newly public Melinta three anti-infective products and a related sales force from The Medicines Co. will enable the latter to downsize and focus on its Phase III PCSK9 inhibitor inclisiran.

Two businessmen shaking hands during a meeting in the office, success, dealing, greeting & business partner concepts - soft light.

More from Deals

More from Business